Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Hamburg - Delayed Quote • EUR Johnson & Johnson (JNJ.HM) Follow Add holdings 136.44 -0.28 (-0.20%) As of 10:04:24 AM GMT+2. Market Open. Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for JNJ.HM 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: JNJ.HM View More All News Press Releases SEC Filings Johnson & Johnson (NYSE:JNJ) Is Paying Out A Larger Dividend Than Last Year ChatGPT Stock Advice: Johnson & Johnson (JNJ) Among Top Stock Recommendations MedTechs Adjust 2025 Outlook Amid Tariffs: What Investors Need to Know Was Jim Cramer Right About Johnson & Johnson (JNJ)? TREMFYA® (guselkumab) positioned to become the first and only IL-23 inhibitor to offer subcutaneous induction in ulcerative colitis as demonstrated in new data through 24 weeks TREMFYA® (guselkumab) delivers sustained clinical and endoscopic remission in ulcerative colitis through two years If You Invested $10K In Johnson & Johnson Stock 10 Years Ago, How Much Would You Have Now? Is Johnson & Johnson (JNJ) The Most Profitable Cheap Stock to Buy Now? Is the Trump Administration About to Cause AbbVie, Eli Lilly, and Johnson & Johnson Stocks to Crash? Q1 earnings pulse check: companies tentative on pharma-specific tariffs 'Declare victory and move on': Eli Lilly CEO on Trump tariff threat